Sagimet Biosciences (SGMT) Enterprise Value (2023 - 2024)
Sagimet Biosciences (SGMT) has 2 years of Enterprise Value data on record, last reported at -$152.5 million in Q3 2024.
- For Q3 2024, Enterprise Value fell 49.79% year-over-year to -$152.5 million; the TTM value through Sep 2024 reached -$152.5 million, down 49.79%, while the annual FY2023 figure was -$94.9 million, N/A changed from the prior year.
- Enterprise Value reached -$152.5 million in Q3 2024 per SGMT's latest filing, up from -$166.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$18.5 million in Q2 2023 and bottomed at -$193.7 million in Q1 2024.